Datamonitor's Pharmaceuticals: United States Industry Guide is an essential resource for top-level data and analysis covering the United States Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

Scope of the Report

* Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

Highlights

* The United States biotechnology market grew by 11.3% in 2007 to reach a value of $84,760 million.

* The US generics market generated total revenues of $30.8 billion in 2007, representing a compound annual growth rate (CAGR) of 16.8% for the period spanning 2003-2007.

* The United States OTC pharmaceuticals market generated total revenues of $25.5 billion in 2008, representing a compound annual growth rate (CAGR) of 3.4% for the period spanning 2004-2008.

* The United States market generated total revenues of $273.9 billion in 2008, representing a compound annual growth rate (CAGR) of 3.7% for the period spanning 2004-2008.

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Publication: 39904
Library Code: OCIG0275
Type: Industry Guide
Format: PDF
Pages: 65